Reducing fear of animals using brain reinforcement techniques
Unconscious reduction of fear through decoded neuro-reinforcement
This study is exploring a new way to help people who are afraid of animals by using brain imaging to change how their brains react to fear, so they won’t have to face their fears directly and can feel more comfortable.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11034117 on NIH RePORTER |
What this research studies
This research aims to help individuals with specific phobias, particularly fear of animals, by using advanced brain imaging techniques to reduce their fear responses without the need for traditional exposure therapy. By employing decoded fMRI information, the study will focus on altering brain activity in the amygdala, which is responsible for fear processing, to create unconscious changes in how patients respond to their fears. Participants will not have to confront their fears directly, making the process less distressing. The study is designed to be rigorous, using a double-blind placebo-controlled approach to ensure reliable results.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who experience specific phobias related to animals and have difficulty undergoing traditional exposure therapy due to high levels of distress.
Not a fit: Patients who do not have specific phobias or those whose fears are not related to animals may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, less distressing treatment option for individuals suffering from specific phobias.
How similar studies have performed: Previous research has shown promise in using neuro-reinforcement techniques for fear reduction, indicating that this approach may be effective.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Craske, Michelle G — University of California Los Angeles
- Study coordinator: Craske, Michelle G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.